Business Context and Reporting Period
This Form 6-K filing by Inventiva S.A., a foreign private issuer, reports the issuance of the Interim Financial Report for the six months ended June 30, 2024. The report was issued on October 14, 2024, and filed with the SEC on October 15, 2024.
Key Financial Metrics
The provided filing text serves as a cover document and does not contain specific financial data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not available in this text. These metrics are contained within the attached Exhibit 99.1 (Interim Financial Report), which is not included in the input source.
Material Changes
The filing text does not provide details on material changes versus the prior comparable period. Investors must refer to the attached Interim Financial Report for comparative analysis.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. Such disclosures are expected to be found in the full Interim Financial Report referenced as Exhibit 99.1.
Investor Verification Checklist
- Verify the specific financial results (revenue, net loss, cash position) in the attached Exhibit 99.1.
- Review the management discussion and analysis within the Interim Financial Report for updates on clinical trial progress and pipeline status.
- Confirm the company's liquidity runway and any recent financing activities detailed in the full report.
- Check for any new risk factors or legal contingencies disclosed in the interim period.